TrialsgrambetaRCTs are beautiful

Patient-facing AI

AI insulin dosing, autonomous diabetic retinopathy screening, AI lifestyle coaching and a generative-AI therapy chatbot.

  • 2025Mathioudakis AI coaching (DPP)⁠Diabetes careIn 368 adults with prediabetes and overweight or obesity, a fully automated AI-led Diabetes Prevention Program was non-inferior to referral to a remote human coach-led DPP for a 12-month composite of weight loss, physical activity and HbA1c.31.7% vs 31.9%Read →
  • 2025Therabot⁠Mental healthIn 210 adults with depressive or anxiety symptoms, or at high risk of an eating disorder, four weeks of Therabot, a generative-AI therapy chatbot reduced symptoms at 4 and 8 weeks compared with a waitlist control.Read →
  • 2024ACCESS⁠Diabetes careIn 164 youths with diabetes at a paediatric diabetes centre, an autonomous AI diabetic eye examination at the point of care increased diabetic eye exam completion within 6 months compared with scripted referral to an eye care provider with education.100% vs 22%Read →
  • 2020Nimri AI insulin dosing⁠Diabetes careIn 108 youths with type 1 diabetes on insulin pump therapy, AI-guided remote insulin dose adjustment every three weeks was non-inferior to physician-guided adjustment for time in target glucose range (70–180 mg/dL) over six months.50.2% vs 51.6%Read →